Jalyn Capsule
Product Images NDC 80725-809

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jalyn (NDC 80725-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Jalyn 01)

FDA Label Image

Chemical Structure (Jalyn 02)

FDA Label Image

Figure 1 (Jalyn 03)

Figure 1 (Jalyn 03)
This is a comparison of the mean changes from the baseline in International Prostate Symptom Score (IPSS) after treatment with Dutasteride + tamsulosin, Dutasteride alone, and Tamsulosin alone. The study involved 1575 participants for each group and the changes were measured over the months of treatment.*
FDA Label Image

Figure 2 (Jalyn 04)

Figure 2 (Jalyn 04)
This is a statistical report showing mean changes from baseline in terms of milliliters per second over different months of treatment. The data includes the number of participants for each treatment group: A Dutasteride + tamsulosin, Dutasteride 0.5 mg, and Tamsulosin 0.4 mg. The study involved a total of 1477 participants for the combination treatment, 1492 participants for Dutasteride 0.5 mg, and 1519 participants for Tamsulosin 0.4 mg.*
FDA Label Image

Principal Display Panel (30 Capsule Bottle Label)

Principal Display Panel (30 Capsule Bottle Label)
This is information about the prescription medication Jalyn, which is a combination of dutasteride and tamsulosin HCI in capsule form. It is important for women or children to avoid using this medication. The capsules should be swallowed whole and not chewed or opened. Each capsule contains 0.5 mg of dutasteride and 0.4 mg of tamsulosin hydrochloride. The usual dosage is one capsule per day. It should be stored at room temperature, and if the safety seal under the cap is broken or missing, the medication should not be used. Jalyn is a trademark of Wayks Therapeutics LC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.